aluates Reports

$ 0.0

Automative

Global Stomach Cancer and Gastric Cancer Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-16I8120

Global and China Stomach Cancer and Gastric Cancer Drugs Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Stomach Cancer and Gastric Cancer Drugs Market Research Report 2025

Code: QYRE-Auto-16I8120

Report

July 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ipsen Pharma

Merck& Co. Inc

Bristol Myers Squibb Company

Eli Lilly

Roche

Novartis

Bayer

Celltrion

TAIHO PHARMACEUTICAL CO., LTD.

Jiangsu Hengrui Medicine Co Ltd

Stomach Cancer and Gastric Cancer Drugs Market Size

The global market for Stomach Cancer and Gastric Cancer Drugs was valued at US$ 4942 million in the year 2024 and is projected to reach a revised size of US$ 11240 million by 2031, growing at a CAGR of 12.6% during the forecast period.

Stomach Cancer and Gastric Cancer Drugs Market

Stomach cancer is the fifth most common cancer in the world

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Stomach Cancer and Gastric Cancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stomach Cancer and Gastric Cancer Drugs.

The Stomach Cancer and Gastric Cancer Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stomach Cancer and Gastric Cancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stomach Cancer and Gastric Cancer Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Stomach Cancer and Gastric Cancer Drugs Market Report

Report Metric	Details
Report Name	Stomach Cancer and Gastric Cancer Drugs Market
Accounted market size in year	US$ 4942 million
Forecasted market size in 2031	US$ 11240 million
CAGR	12.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Programmed Cell Death Protein 1 (PD-1) Inhibitors Human Epidermal Growth Factor Receptor (HER2) Antagonists Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Others
Segment by Application	Hospitals Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ipsen Pharma, Merck & Co., Inc., Bristol-Myers Squibb Company, Eli Lilly, Roche, Novartis AG, Bayer AG, Celltrion Inc., TAIHO PHARMACEUTICAL CO., LTD., Jiangsu Hengrui Medicine Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stomach Cancer and Gastric Cancer Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Stomach Cancer and Gastric Cancer Drugs Market growing?

Ans: The Stomach Cancer and Gastric Cancer Drugs Market witnessing a CAGR of 12.6% during the forecast period 2025-2031.

What is the Stomach Cancer and Gastric Cancer Drugs Market size in 2031?

Ans: The Stomach Cancer and Gastric Cancer Drugs Market size in 2031 will be US$ 11240 million.

Who are the main players in the Stomach Cancer and Gastric Cancer Drugs Market report?

Ans: The main players in the Stomach Cancer and Gastric Cancer Drugs Market are Ipsen Pharma, Merck & Co., Inc., Bristol-Myers Squibb Company, Eli Lilly, Roche, Novartis AG, Bayer AG, Celltrion Inc., TAIHO PHARMACEUTICAL CO., LTD., Jiangsu Hengrui Medicine Co., Ltd.

What are the Application segmentation covered in the Stomach Cancer and Gastric Cancer Drugs Market report?

Ans: The Applications covered in the Stomach Cancer and Gastric Cancer Drugs Market report are Hospitals, Clinics

What are the Type segmentation covered in the Stomach Cancer and Gastric Cancer Drugs Market report?

Ans: The Types covered in the Stomach Cancer and Gastric Cancer Drugs Market report are Programmed Cell Death Protein 1 (PD-1) Inhibitors, Human Epidermal Growth Factor Receptor (HER2) Antagonists, Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists, Others

Recommended Reports

Cancer Drug Markets

Gastrointestinal Disease Therapy

Oncology Diagnostics and Care

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Programmed Cell Death Protein 1 (PD-1) Inhibitors

1.2.3 Human Epidermal Growth Factor Receptor (HER2) Antagonists

1.2.4 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists

1.2.5 Others

1.3 Market by Application

1.3.1 Global Stomach Cancer and Gastric Cancer Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Stomach Cancer and Gastric Cancer Drugs Market Perspective (2020-2031)

2.2 Global Stomach Cancer and Gastric Cancer Drugs Growth Trends by Region

2.2.1 Global Stomach Cancer and Gastric Cancer Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Stomach Cancer and Gastric Cancer Drugs Historic Market Size by Region (2020-2025)

2.2.3 Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Region (2026-2031)

2.3 Stomach Cancer and Gastric Cancer Drugs Market Dynamics

2.3.1 Stomach Cancer and Gastric Cancer Drugs Industry Trends

2.3.2 Stomach Cancer and Gastric Cancer Drugs Market Drivers

2.3.3 Stomach Cancer and Gastric Cancer Drugs Market Challenges

2.3.4 Stomach Cancer and Gastric Cancer Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Stomach Cancer and Gastric Cancer Drugs Players by Revenue

3.1.1 Global Top Stomach Cancer and Gastric Cancer Drugs Players by Revenue (2020-2025)

3.1.2 Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Stomach Cancer and Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Stomach Cancer and Gastric Cancer Drugs Revenue

3.4 Global Stomach Cancer and Gastric Cancer Drugs Market Concentration Ratio

3.4.1 Global Stomach Cancer and Gastric Cancer Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stomach Cancer and Gastric Cancer Drugs Revenue in 2024

3.5 Global Key Players of Stomach Cancer and Gastric Cancer Drugs Head office and Area Served

3.6 Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Product and Application

3.7 Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Stomach Cancer and Gastric Cancer Drugs Breakdown Data by Type

4.1 Global Stomach Cancer and Gastric Cancer Drugs Historic Market Size by Type (2020-2025)

4.2 Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Type (2026-2031)

5 Stomach Cancer and Gastric Cancer Drugs Breakdown Data by Application

5.1 Global Stomach Cancer and Gastric Cancer Drugs Historic Market Size by Application (2020-2025)

5.2 Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Stomach Cancer and Gastric Cancer Drugs Market Size (2020-2031)

6.2 North America Stomach Cancer and Gastric Cancer Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2020-2025)

6.4 North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Stomach Cancer and Gastric Cancer Drugs Market Size (2020-2031)

7.2 Europe Stomach Cancer and Gastric Cancer Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2020-2025)

7.4 Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size (2020-2031)

8.2 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size (2020-2031)

9.2 Latin America Stomach Cancer and Gastric Cancer Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2020-2025)

9.4 Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size (2020-2031)

10.2 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Ipsen Pharma

11.1.1 Ipsen Pharma Company Details

11.1.2 Ipsen Pharma Business Overview

11.1.3 Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Introduction

11.1.4 Ipsen Pharma Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.1.5 Ipsen Pharma Recent Development

11.2 Merck & Co., Inc.

11.2.1 Merck & Co., Inc. Company Details

11.2.2 Merck & Co., Inc. Business Overview

11.2.3 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Drugs Introduction

11.2.4 Merck & Co., Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.2.5 Merck & Co., Inc. Recent Development

11.3 Bristol-Myers Squibb Company

11.3.1 Bristol-Myers Squibb Company Company Details

11.3.2 Bristol-Myers Squibb Company Business Overview

11.3.3 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Introduction

11.3.4 Bristol-Myers Squibb Company Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.3.5 Bristol-Myers Squibb Company Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Details

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Stomach Cancer and Gastric Cancer Drugs Introduction

11.4.4 Eli Lilly Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.4.5 Eli Lilly Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Stomach Cancer and Gastric Cancer Drugs Introduction

11.5.4 Roche Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Novartis AG

11.6.1 Novartis AG Company Details

11.6.2 Novartis AG Business Overview

11.6.3 Novartis AG Stomach Cancer and Gastric Cancer Drugs Introduction

11.6.4 Novartis AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.6.5 Novartis AG Recent Development

11.7 Bayer AG

11.7.1 Bayer AG Company Details

11.7.2 Bayer AG Business Overview

11.7.3 Bayer AG Stomach Cancer and Gastric Cancer Drugs Introduction

11.7.4 Bayer AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.7.5 Bayer AG Recent Development

11.8 Celltrion Inc.

11.8.1 Celltrion Inc. Company Details

11.8.2 Celltrion Inc. Business Overview

11.8.3 Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Introduction

11.8.4 Celltrion Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.8.5 Celltrion Inc. Recent Development

11.9 TAIHO PHARMACEUTICAL CO., LTD.

11.9.1 TAIHO PHARMACEUTICAL CO., LTD. Company Details

11.9.2 TAIHO PHARMACEUTICAL CO., LTD. Business Overview

11.9.3 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Introduction

11.9.4 TAIHO PHARMACEUTICAL CO., LTD. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.9.5 TAIHO PHARMACEUTICAL CO., LTD. Recent Development

11.10 Jiangsu Hengrui Medicine Co., Ltd.

11.10.1 Jiangsu Hengrui Medicine Co., Ltd. Company Details

11.10.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview

11.10.3 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Introduction

11.10.4 Jiangsu Hengrui Medicine Co., Ltd. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

11.10.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ipsen Pharma

Merck& Co. Inc

Bristol Myers Squibb Company

Eli Lilly

Roche

Novartis

Bayer

Celltrion

TAIHO PHARMACEUTICAL CO., LTD.

Jiangsu Hengrui Medicine Co Ltd

List of Tables

Table 1. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Programmed Cell Death Protein 1 (PD-1) Inhibitors

Table 3. Key Players of Human Epidermal Growth Factor Receptor (HER2) Antagonists

Table 4. Key Players of Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists

Table 5. Key Players of Others

Table 6. Global Stomach Cancer and Gastric Cancer Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Region (2020-2025)

Table 10. Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Region (2026-2031)

Table 12. Stomach Cancer and Gastric Cancer Drugs Market Trends

Table 13. Stomach Cancer and Gastric Cancer Drugs Market Drivers

Table 14. Stomach Cancer and Gastric Cancer Drugs Market Challenges

Table 15. Stomach Cancer and Gastric Cancer Drugs Market Restraints

Table 16. Global Stomach Cancer and Gastric Cancer Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Players (2020-2025)

Table 18. Global Top Stomach Cancer and Gastric Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stomach Cancer and Gastric Cancer Drugs as of 2024)

Table 19. Ranking of Global Top Stomach Cancer and Gastric Cancer Drugs Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Stomach Cancer and Gastric Cancer Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Headquarters and Area Served

Table 22. Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Product and Application

Table 23. Global Key Players of Stomach Cancer and Gastric Cancer Drugs, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Type (2020-2025)

Table 27. Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Type (2026-2031)

Table 29. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Application (2020-2025)

Table 31. Global Stomach Cancer and Gastric Cancer Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Stomach Cancer and Gastric Cancer Drugs Revenue Market Share by Application (2026-2031)

Table 33. North America Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. Ipsen Pharma Company Details

Table 49. Ipsen Pharma Business Overview

Table 50. Ipsen Pharma Stomach Cancer and Gastric Cancer Drugs Product

Table 51. Ipsen Pharma Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 52. Ipsen Pharma Recent Development

Table 53. Merck & Co., Inc. Company Details

Table 54. Merck & Co., Inc. Business Overview

Table 55. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Drugs Product

Table 56. Merck & Co., Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 57. Merck & Co., Inc. Recent Development

Table 58. Bristol-Myers Squibb Company Company Details

Table 59. Bristol-Myers Squibb Company Business Overview

Table 60. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Drugs Product

Table 61. Bristol-Myers Squibb Company Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 62. Bristol-Myers Squibb Company Recent Development

Table 63. Eli Lilly Company Details

Table 64. Eli Lilly Business Overview

Table 65. Eli Lilly Stomach Cancer and Gastric Cancer Drugs Product

Table 66. Eli Lilly Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 67. Eli Lilly Recent Development

Table 68. Roche Company Details

Table 69. Roche Business Overview

Table 70. Roche Stomach Cancer and Gastric Cancer Drugs Product

Table 71. Roche Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 72. Roche Recent Development

Table 73. Novartis AG Company Details

Table 74. Novartis AG Business Overview

Table 75. Novartis AG Stomach Cancer and Gastric Cancer Drugs Product

Table 76. Novartis AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 77. Novartis AG Recent Development

Table 78. Bayer AG Company Details

Table 79. Bayer AG Business Overview

Table 80. Bayer AG Stomach Cancer and Gastric Cancer Drugs Product

Table 81. Bayer AG Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 82. Bayer AG Recent Development

Table 83. Celltrion Inc. Company Details

Table 84. Celltrion Inc. Business Overview

Table 85. Celltrion Inc. Stomach Cancer and Gastric Cancer Drugs Product

Table 86. Celltrion Inc. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 87. Celltrion Inc. Recent Development

Table 88. TAIHO PHARMACEUTICAL CO., LTD. Company Details

Table 89. TAIHO PHARMACEUTICAL CO., LTD. Business Overview

Table 90. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Drugs Product

Table 91. TAIHO PHARMACEUTICAL CO., LTD. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 92. TAIHO PHARMACEUTICAL CO., LTD. Recent Development

Table 93. Jiangsu Hengrui Medicine Co., Ltd. Company Details

Table 94. Jiangsu Hengrui Medicine Co., Ltd. Business Overview

Table 95. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Drugs Product

Table 96. Jiangsu Hengrui Medicine Co., Ltd. Revenue in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025) & (US$ Million)

Table 97. Jiangsu Hengrui Medicine Co., Ltd. Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Stomach Cancer and Gastric Cancer Drugs Picture

Figure 2. Global Stomach Cancer and Gastric Cancer Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Type: 2024 VS 2031

Figure 4. Programmed Cell Death Protein 1 (PD-1) Inhibitors Features

Figure 5. Human Epidermal Growth Factor Receptor (HER2) Antagonists Features

Figure 6. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Features

Figure 7. Others Features

Figure 8. Global Stomach Cancer and Gastric Cancer Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. Stomach Cancer and Gastric Cancer Drugs Report Years Considered

Figure 13. Global Stomach Cancer and Gastric Cancer Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Stomach Cancer and Gastric Cancer Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Stomach Cancer and Gastric Cancer Drugs Market Share by Players in 2024

Figure 17. Global Top Stomach Cancer and Gastric Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stomach Cancer and Gastric Cancer Drugs as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Stomach Cancer and Gastric Cancer Drugs Revenue in 2024

Figure 19. North America Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2020-2031)

Figure 21. United States Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2020-2031)

Figure 25. Germany Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Stomach Cancer and Gastric Cancer Drugs Market Share by Region (2020-2031)

Figure 33. China Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Stomach Cancer and Gastric Cancer Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Stomach Cancer and Gastric Cancer Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Ipsen Pharma Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 49. Merck & Co., Inc. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 51. Eli Lilly Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 53. Novartis AG Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 54. Bayer AG Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 55. Celltrion Inc. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 56. TAIHO PHARMACEUTICAL CO., LTD. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 57. Jiangsu Hengrui Medicine Co., Ltd. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Drugs Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Gastric Carcinomas Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastric Cancer Drugs Market Research Report 2024

Global Stomach Cancer Drugs Market Insights Forecast to 2030

Gynaecological Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Delivery in Cancer Market Insights Forecast to 2030

Global Metastatic Colorectal Cancer Drug Market Insights Forecast to 2030

Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stomach Cancer Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lansoprazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COPD Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stomach Cancer Molecular Diagnostics Market Research Report 2024

Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sorafenib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Breast Cancer Targeted Drug Market Research Report 2025

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030

Pet Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions